There is a strong consensus that an ideal diagnostic test should be rapid, noninvasive, reagentless, inexpensive, and suitable for application at the point of care. For most tests, this ideal is a distant prospect. One recent success has been reflectance spectrophotometry, which is now used for transcutaneous bilirubin measurements in neonates (BiliCheck™; http://bilichek. respironics.com). Another is the noninvasive measurement of blood oxygen saturation using red and infrared absorption measurements (e.g., 660 and 920 nm). However, early hope for a broad range of infraredbased noninvasive testing has been dashed. Although successful for oxygen saturation, the expansion of the scope of this technology to the main prize, namely blood glucose, has not been successful, and in fact has been the source of major controversy.In view of the slow progress in reagentless noninvasive technologies, efforts have continued in ways to reduce the number of steps, reagents, and manipulations in more conventional assays, particularly for disposable assays intended for point of care, where speed, error-free operation, and ease of use are paramount.In the current range of point-of-care tests, 2 endpoints dominate. The first and earliest point-of-care tests were portable tablet-and powder-based colorimetric assays that were available in the early twentieth century. The second generation of point-of-care test devices was based on electrochemical measurements using a meter. Many assays have been effectively reduced to a single-addition-and-read format; for multistep point-of-care assays, such as immunoassays, assay simplification has been achieved using self-contained cartridges that enable reagent and sample manipulations, as exemplified by lateral flow devices.Magnetism is emerging as a possible source of point-of-care assay innovation (1 ). The exploitation of magnetism in clinical assays is not new. Magnetic particles are commonly used as solid phases for immobilizing reagents to facilitate separation after incubation or washing steps, but can also used as components of a detection technology. Magnetic particles have been used to measure clot formation times by monitoring the effect of a magnetic field on the motion of magnetic particles mixed with a blood sample in a small chamber on a credit card-sized cassette. Interestingly, another type of coagulation assay measures changes in viscosity by magnetoelastic sensors in an essentially particle-free and reagent-free manner. Magnetic labels have also been used in immunoassay (magneto-immunoassay) and in polynucleotide assays. These labels include superparamagnetic iron oxide nanoparticles detected using a superconducting quantum interference device (SQUID), 3 and paramagnetic materials and dextrancoated nanoscale superparamagnetic particles detected using a magnetic permeability detector.A recent series of studies has fueled interest in magnetoresistance in bioassays and has demonstrated the feasibility of a disposable assay system based on giant magnetoresistance (GMR) (2, 3 ). GM...